title: Rapid changes in cardiac myofilament function following the acute activation of estrogen receptor-alpha.
abstract: Estrogens have well-recognized and complex cardiovascular effects, including altering myocardial contractility through changes in myofilament function. The presence of multiple estrogen receptor (ER) isoforms in the heart may explain some discrepant findings about the cardiac effects of estrogens. Most studies examining the impact of estrogens on the heart have focused on chronic changes in estrogen levels, and have not investigated rapid, non-genomic pathways. The first objective of this study was to determine how acute activation of ERα impacts cardiac myofilaments. Nongenomic myocardial estrogen signaling is associated with the activation of a variety of signaling pathways. p38 MAPK has been implicated in acute ER signaling in the heart, and is known to affect myofilament function. Thus, the second objective of this study was to determine if acute ERα activation mediates its myofilament effects through p38 MAPK recruitment. Hearts from female C57Bl/6 mice were perfused with the ERα agonist PPT and myofilaments isolated. Activation of ERα depressed actomyosin MgATPase activity and decreased myofilament calcium sensitivity. Inhibition of p38 MAPK attenuated the myofilament effects of ERα activation. ERα stimulation did not affect global myofilament protein phosphorylation, but troponin I phosphorylation at the putative PKA phosphorylation sites was decreased. Changes in myofilament activation did not translate into alterations in whole heart function. The present study provides evidence supporting rapid, non-genomic changes in cardiac myofilament function following acute ERα stimulation mediated by the p38 MAPK pathway.
authors.affiliation: Cardiovascular Research Group, Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
authors.forename: Justyna
authors.initials: J
authors.lastname: Kulpa
authors.forename: Nirmala
authors.initials: N
authors.lastname: Chinnappareddy
authors.forename: W Glen
authors.initials: WG
authors.lastname: Pyle
mesh_terms: D000818:Animals; D047628:Estrogen Receptor alpha / Q000378:metabolism* / Q000502:physiology; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D006352:Heart Ventricles / Q000166:cytology*; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D051379:Mice; D008810:Mice, Inbred C57BL; D009124:Muscle Proteins / Q000378:metabolism; D009210:Myofibrils / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D010636:Phenols / Q000494:pharmacology; D010766:Phosphorylation; D011499:Protein Processing, Post-Translational; D011720:Pyrazoles / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D019210:Troponin I / Q000378:metabolism; D016277:Ventricular Function, Left / Q000187:drug effects; D017725:Ventricular Pressure / Q000187:drug effects; D048051:p38 Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D047628:Estrogen Receptor alpha; D004967:Estrogens; D007093:Imidazoles; D009124:Muscle Proteins; D010636:Phenols; D011720:Pyrazoles; D011725:Pyridines; D019210:Troponin I; C486184:4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol; D048051:p38 Mitogen-Activated Protein Kinases; C093642:SB 203580